Anti-androgen 2-hydroxyflutamide modulates cadherin, catenin and androgen receptor phosphorylation in androgen-sensitive LNCaP and androgen-independent PC3 prostate cancer cell lines acting via PI3K/Akt and MAPK/ERK1/2 pathways.
about
Anti-androgen 2-hydroxyflutamide modulates cadherin, catenin and androgen receptor phosphorylation in androgen-sensitive LNCaP and androgen-independent PC3 prostate cancer cell lines acting via PI3K/Akt and MAPK/ERK1/2 pathways.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Anti-androgen 2-hydroxyflutami ...... /Akt and MAPK/ERK1/2 pathways.
@en
type
label
Anti-androgen 2-hydroxyflutami ...... /Akt and MAPK/ERK1/2 pathways.
@en
prefLabel
Anti-androgen 2-hydroxyflutami ...... /Akt and MAPK/ERK1/2 pathways.
@en
P2093
P1433
P1476
Anti-androgen 2-hydroxyflutami ...... /Akt and MAPK/ERK1/2 pathways.
@en
P2093
Alicja Kamińska
Anna Hejmej
Ewelina Górowska-Wójtowicz
Joanna Dulińska-Litewka
Laura Pardyak
Małgorzata Kotula-Balak
Piotr Laidler
P304
P356
10.1016/J.TIV.2017.01.019
P577
2017-02-02T00:00:00Z